63 related articles for article (PubMed ID: 1407615)
1. [Hemostatic parameters in patients with type IIA and IV hyperlipoproteinemia].
Ferlito S; Torrisi A; Marangio S; Palermo A; Condorelli M; Mazzone D
Minerva Cardioangiol; 1992 Jun; 40(6):211-7. PubMed ID: 1407615
[TBL] [Abstract][Full Text] [Related]
2. [Prothrombotic and prethrombotic markers in obese diabetic and non-diabetic subjects].
Ferlito S; Di Mauro V; Palermo A; Mazzone D; Condorelli M; Papalia D
Minerva Cardioangiol; 1991; 39(1-2):21-8. PubMed ID: 1830376
[TBL] [Abstract][Full Text] [Related]
3. Haemostatic balance in patients with acute focal cerebral vasculopathy.
Ferlito S; Condorelli M; Mazzone D
Panminerva Med; 1994 Dec; 36(4):184-7. PubMed ID: 7603735
[TBL] [Abstract][Full Text] [Related]
4. [The thrombophilic status and ischemic cardiopathy].
Ferlito S; Torrisi A; Marangio S; Palermo A; Condorelli M; Mazzone D
Minerva Cardioangiol; 1991 May; 39(5):167-76. PubMed ID: 1956544
[TBL] [Abstract][Full Text] [Related]
5. [Hemostatic status in subjects with deep venous thrombosis].
Ferlito S; Bonomo T; Pitari G; Puleo R; Condorelli M; Mazzone D
Minerva Cardioangiol; 1996 Dec; 44(12):649-53. PubMed ID: 9053819
[TBL] [Abstract][Full Text] [Related]
6. Blood coagulation, fibrinolytic activity and lipid profile in subclinical thyroid disease: subclinical hyperthyroidism increases plasma factor X activity.
Erem C
Clin Endocrinol (Oxf); 2006 Mar; 64(3):323-9. PubMed ID: 16487444
[TBL] [Abstract][Full Text] [Related]
7. Acute lipidemic effect of calcium heparin in normolipemic and hyperlipemic subjects.
Ferlito S; Ricceri M; Ossino AM
Int Angiol; 1989; 8(3):140-4. PubMed ID: 2592796
[TBL] [Abstract][Full Text] [Related]
8. Blood coagulation, fibrinolysis and lipid profile in patients with primary hyperparathyroidism: increased plasma factor VII and X activities and D-Dimer levels.
Erem C; Kocak M; Hacihasanoglu A; Yilmaz M; Saglam F; Ersoz HO
Exp Clin Endocrinol Diabetes; 2008 Nov; 116(10):619-24. PubMed ID: 18484067
[TBL] [Abstract][Full Text] [Related]
9. Alpha 2-antiplasmin, plasminogen activator inhibitor (PAI) and dilute blood clot lysis time in selected disease states.
Cucuianu M; Knauer O; Roman S
Thromb Haemost; 1991 Nov; 66(5):586-91. PubMed ID: 1725069
[TBL] [Abstract][Full Text] [Related]
10. Changes in haemostatic variables induced by oral contraceptives containing 50 micrograms or 30 micrograms oestrogen: absence of dose-dependent effect on PAI-1 activity.
Scarabin PY; Plu-Bureau G; Zitoun D; Bara L; Guize L; Samama MM
Thromb Haemost; 1995 Sep; 74(3):928-32. PubMed ID: 8571323
[TBL] [Abstract][Full Text] [Related]
11. [Estimation of the correlation between hemostatic parameters and serum lipids in patients with hyperlipidemia type II after simvastatin therapy].
Broncel M; Marczyk I; Kostka B; Michalska M; Sikora J; Chojnowska-Jezierska J
Pol Merkur Lekarski; 2007 Jan; 22(127):21-4. PubMed ID: 17477084
[TBL] [Abstract][Full Text] [Related]
12. [Changes in the level of certain hemostatic factors during treatment with lovastatin in patients with primary hyperlipoproteinemia and phenotype IIa and IIb].
Idzior-Waluś B
Przegl Lek; 1992; 49(10):334-9. PubMed ID: 1308287
[TBL] [Abstract][Full Text] [Related]
13. [Fibrinogen and antithrombin III in obese subjects].
Ferlito S; Palermo A; Mazzone D; Condorelli M; Papalia D
Minerva Endocrinol; 1990; 15(2):145-8. PubMed ID: 2098657
[TBL] [Abstract][Full Text] [Related]
14. Haemostatic abnormalities persist despite glycaemic improvement by insulin therapy in lean type 2 diabetic patients.
Knöbl P; Schernthaner G; Schnack C; Pietschmann P; Proidl S; Prager R; Vukovich T
Thromb Haemost; 1994 Jun; 71(6):692-7. PubMed ID: 7974333
[TBL] [Abstract][Full Text] [Related]
15. Changes induced by gemfibrozil on lipidic, coagulative and fibrinolytic pattern in patients with type IV hyperlipoproteinemia.
Avellone G; Di Garbo V; Panno AV; Cordova R; Lepore R; Strano A
Int Angiol; 1988; 7(3):270-7. PubMed ID: 3198979
[TBL] [Abstract][Full Text] [Related]
16. Fibrinogen, factor VII, antithrombin III, cholesterol and triglycerides in young men with myocardial infarction and in their sons.
Jastrzebska M; Torbus-Lisiecka B; Pieczul-Mróz J; Chełstowski K; Naruszewicz M
Mater Med Pol; 1997; 29(1-4):3-7. PubMed ID: 10214462
[TBL] [Abstract][Full Text] [Related]
17. [The relationships between the lipoprotein profile and rheological-coagulation parameters in patients with hyperlipoproteinemia type II].
Bo M; Molaschi M; Neirotti M; Bonino F; Gottero M; Pedrazzini V; Mainardi S; Fabris F
Recenti Prog Med; 1992 Apr; 83(4):189-93. PubMed ID: 1626110
[TBL] [Abstract][Full Text] [Related]
18. Effects of an oral fat load on some prothrombotic markers in coronary heart patients.
Ferlito S; Di Mauro C
Panminerva Med; 1990; 32(3):101-4. PubMed ID: 2077474
[TBL] [Abstract][Full Text] [Related]
19. [Primary hyperlipoproteinemia in its clinical and laboratory aspects. IV. Blood coagulation and fibrinolysis indicators].
Borodin M; Jurek D; Gregorczyk J; Pieczul-Mróz J; Cwajda H
Przegl Lek; 1983; 40(10):727-32. PubMed ID: 6665208
[No Abstract] [Full Text] [Related]
20. [Platelet half-life in patients with primary hyperlipoproteinemia type IIa, IIb, and IV according to Fredrickson with and without clinical signs of atherosclerosis].
Jäger E; Sinzinger H; Widhalm K; Kaliman J; Höfer R
Wien Klin Wochenschr; 1982 Sep; 94(16):421-5. PubMed ID: 7147981
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
